News | December 21, 2023
AGC invests US$ 348 million to expand its biopharmaceutical CDMO capability
Development services for gene and cell therapies is planned to begin first in 2025
Development services for gene and cell therapies is planned to begin first in 2025
KBR will provide outreach, education and data analytics to support critical neuroscience research for the prevention and treatment of military members with CTE
The launch of R3SET Detox Candies positions the brand at the forefront of the wellness journey
Five batches across four programs of Biocon Academy participated in the graduation ceremony
Fischer Chemic will make an entry into the growing market of diagnostic imaging industry with innovative and disruptive technologies
The Regional Reference Laboratory in Chennai is equipped with cutting-edge diagnostic technologies
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
Expands patient reach to remotest towns by furthering investment in GoApptiv
This development is a strategic part of the company's commitment to bolstering its position in the advanced pharmaceutical intermediates segment
Expansion of presence in India with electrical safety, electromagnetic compatibility and medical device biocompatibility, toxicity and microbiology testing and certification services
Subscribe To Our Newsletter & Stay Updated
